# ENVB (Enveric Biosciences, Inc.) - SEC EDGAR Financial Statements

> Enveric Biosciences, Inc. reported $6.37M in total assets and a net loss of $9.40M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/ENVB
- Markdown: https://convexityos.com/fundamentals/ENVB.md
- SEC CIK: 0000890821
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:08 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000890821&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$9.42M | Operating profit |
| Net Income | FY 2025 | -$9.40M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.10 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $5.61M | Total debt: -- |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | -- | -- | -- | -- | -- | -- | $39.91M | $43.00M | $48.59M | $36.15M |
| Cost of Revenue | -- | -- | -- | -- | -- | -- | $31.76M | $34.01M | $38.36M | $29.22M |
| **Gross Profit** | -- | -- | -- | -- | -- | -- | $8.15M | $8.98M | $10.24M | $6.93M |
| Research & Development | $2.78M | $2.84M | $7.25M | $8.03M | $4.79M | $174K | -- | -- | -- | -- |
| Selling, General & Admin | -- | -- | -- | -- | $20.50M | $5.32M | $2.30M | $10.79M | $18.51M | $9.36M |
| Total Operating Expenses | -- | -- | -- | -- | -- | -- | $14.48M | $16.13M | $21.13M | $12.31M |
| **Operating Income** | -$8.77M | -$9.63M | -$16.45M | -$27.42M | -$64.62M | -$5.62M | -$2.30M | -$7.15M | -$10.90M | -$5.38M |
| **EBITDA** | -$8.57M | -$9.29M | -$16.10M | -$27.09M | -$63.97M | -$5.50M | -$31K | -$4.24M | -$7.68M | -$4.02M |
| Interest Expense | -- | -- | -- | $5.2K | $10K | $445K | $82K | $730K | $575K | $751K |
| Income Before Tax | -$8.77M | -$9.57M | -$17.26M | -$19.96M | -$56.43M | -$6.86M | -$5.22M | -$10.55M | -$11.47M | -$6.53M |
| Income Tax Expense | -- | $8.9K | $29K | -$1.49M | -$7.45M | -- | $389K | $6.35M | -$2.39M | -$3.75M |
| **Net Income** | -$8.77M | -$9.57M | -$17.29M | -$18.47M | -$48.98M | -$6.86M | -$2.41M | -$16.90M | -$9.07M | -$2.78M |
| Basic EPS | -$36.24 | -$228.48 | -$260,011.15 | -$418,024.35 | -$166,711,327.39 | -$1,913,265.31 | -$4,550,034.30 | -$32,911,378.84 | -$30,145,986.97 | -$8,440,876.35 |
| **Diluted EPS** | -$36.24 | -$228.48 | -$260,011.15 | -$418,024.35 | -$3,328,116.96 | -$1,913,265.31 | -$4,550,034.30 | -$32,911,378.84 | -$30,145,986.97 | -$8,440,876.35 |
| Basic Shares Outstanding | 334.7K | 41.9K | 67 | 45 | 0 | 4 | 3 | 1 | 0 | 0 |
| Diluted Shares Outstanding | 334.7K | 41.9K | 67 | 45 | 15 | 4 | 1 | 1 | 0 | 0 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $1.35M | $1.36M | $346K | $372K | $402K | $1.26M | $746K | $967K |
| Total Operating Expenses | $2.56M | $3.03M | -- | -- | $1.87M | $2.52M | -- | -- |
| **Operating Income** | -$2.56M | -$3.03M | -$1.63M | -$2.19M | -$1.87M | -$2.52M | -$2.19M | -$3.17M |
| **EBITDA** | -$2.53M | -$2.99M | -$1.60M | -$2.15M | -$1.83M | -$2.48M | -$2.11M | -$3.09M |
| Income Before Tax | -$2.55M | -$3.03M | -$1.63M | -$2.19M | -$1.87M | -$2.52M | -$2.18M | -$3.15M |
| Income Tax Expense | -- | -- | -- | -- | -- | -- | -- | $7.2K |
| **Net Income** | -$2.55M | -$3.03M | -$1.63M | -$2.19M | -$1.87M | -$2.52M | -$2.18M | -$3.15M |
| Basic EPS | -$0.57 | -$0.76 | -$1.08 | -- | -$10.81 | -$11.65 | -$14.58 | -- |
| **Diluted EPS** | -$0.57 | -$0.76 | -$1.08 | -- | -$10.81 | -$11.65 | -$14.58 | -- |
| Basic Shares Outstanding | 4.5M | 4.0M | 1.5M | -- | 313.2K | 216.3K | 149.8K | -- |
| Diluted Shares Outstanding | 4.5M | 4.0M | 1.5M | -- | 313.2K | 216.3K | 149.8K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $4.68M | $2.24M | $2.29M | $17.72M | $17.36M | $1.58M | $431K | $1.37M | $4.88M | $1.38M |
| Short-Term Investments | -- | -- | -- | -- | -- | -- | -- | -- | -- | $83K |
| **Cash & Short-Term Investments** | $4.68M | $2.24M | $2.29M | $17.72M | $17.36M | $1.58M | $431K | $1.37M | $4.88M | $1.46M |
| Accounts Receivable, Net | -- | -- | -- | -- | -- | -- | $6.38M | $7.87M | $8.84M | $8.06M |
| Other Current Assets | -- | -- | -- | -- | -- | -- | $784K | $819K | $924K | $625K |
| **Total Current Assets** | $4.94M | $2.73M | $3.58M | $18.43M | $17.74M | $2.28M | $109K | $10.06M | $14.64M | $10.06M |
| Property, Plant & Equipment, Net | $159K | $306K | $507K | $677K | $294K | -- | $83K | $59K | $95K | $100K |
| Goodwill | -- | -- | -- | $380K | $1.59M | -- | $13.73M | $13.73M | $21.90M | $17.09M |
| Intangible Assets | -- | $42K | $211K | $380K | $6.92M | $1.82M | $3.58M | $5.78M | $9.47M | $8.76M |
| **Total Non-Current Assets** | $159K | $348K | $718K | $1.12M | $8.98M | $1.82M | $17.69M | $19.58M | $37.55M | $29.44M |
| **Total Assets** | $5.10M | $3.08M | $4.30M | $19.55M | $26.72M | $4.10M | $109K | $29.64M | $52.20M | $39.51M |
| Accounts Payable | $581K | $522K | $1.22M | $463K | $683K | -- | $4.70M | $4.38M | $5.32M | $5.13M |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | $0 | $5.21M | $5.55M | $3.90M |
| Other Current Liabilities | $100K | $233K | $24K | $851K | -- | -- | $236K | $283K | $388K | $567K |
| **Total Current Liabilities** | $918K | $1.49M | $2.34M | $4.00M | $2.74M | $681K | $13.50M | $14.69M | $30.37M | $12.71M |
| Long-Term Debt | -- | -- | -- | -- | -- | -- | -- | $0 | $1.13M | $1.54M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $1.68M | $0 | $1.17M | $4.19M | $2.38M | $15.14M |
| **Total Liabilities** | $918K | $1.49M | $2.34M | $4.00M | $4.41M | $681K | $1.92M | $18.88M | $32.75M | $27.84M |
| **Total Debt (incl. Leases)** | -- | -- | -- | $64K | $176K | -- | $290K | $5.21M | $6.68M | $5.44M |
| Common Stock | $11K | $565 | $1.8K | $21K | $6.5K | $101K | $53K | $17K | $182K | $139K |
| Retained Earnings | -$114.8M | -$106.1M | -$96.50M | -$79.21M | -$60.74M | -$11.76M | -$4.89M | -$34.48M | -$15.00M | -$3.83M |
| Accumulated Other Comp. Income | -$580K | -$595K | -$570K | -$537K | -$31K | -$181K | -$12K | $87K | $37K | -$7.4K |
| **Total Stockholders' Equity** | $4.18M | $1.59M | $1.96M | $14.67M | $22.31M | $3.42M | -$1.81M | -$65K | $19.45M | $11.66M |
| Total Equity | $4.18M | $1.59M | $1.96M | $14.67M | $22.31M | $3.42M | -$1.81M | $10.76M | $19.45M | $11.66M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $5.61M | $8.30M | $4.91M | $4.68M | $3.76M | $2.85M | $4.29M | $2.24M |
| **Cash & Short-Term Investments** | $5.61M | $8.30M | $4.91M | $4.68M | $3.76M | $2.85M | $4.29M | $2.24M |
| **Total Current Assets** | $6.25M | $8.79M | $5.38M | $4.94M | $4.17M | $3.31M | $4.83M | $2.73M |
| Property, Plant & Equipment, Net | $48K | $82K | $120K | $159K | $197K | $241K | $267K | $306K |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | $42K |
| **Total Non-Current Assets** | $124K | $151K | $146K | $159K | $197K | $241K | $267K | $348K |
| **Total Assets** | $6.37M | $8.94M | $5.52M | $5.10M | $4.36M | $3.55M | $5.10M | $3.08M |
| Accounts Payable | $407K | $683K | $280K | $581K | $684K | $1.04M | $669K | $522K |
| Other Current Liabilities | -- | -- | -- | $100K | -- | -- | -- | $233K |
| **Total Current Liabilities** | $644K | $861K | $461K | $918K | $906K | $1.36M | $1.18M | $1.49M |
| **Total Non-Current Liabilities** | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| **Total Liabilities** | $644K | $861K | $461K | $918K | $906K | $1.36M | $1.18M | $1.49M |
| Common Stock | $45K | $39K | $19K | $11K | $5.2K | $30K | $25K | $565 |
| Retained Earnings | -$122.1M | -$119.5M | -$116.5M | -$114.8M | -$112.7M | -$110.8M | -$108.3M | -$106.1M |
| Accumulated Other Comp. Income | -$599K | -$595K | -$587K | -$580K | -$581K | -$574K | -$598K | -$595K |
| **Total Stockholders' Equity** | $5.73M | $8.08M | $5.06M | $4.18M | $3.46M | $2.18M | $3.92M | $1.59M |
| Total Equity | $5.73M | $8.08M | $5.06M | $4.18M | $3.46M | $2.18M | $3.92M | $1.59M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$8.77M | -$9.57M | -$17.29M | -$18.47M | -$48.98M | -$6.86M | -$2.41M | -$16.90M | -$9.07M | -$2.78M |
| Depreciation & Amortization | $201K | $337K | $344K | $328K | $657K | $121K | $2.27M | $2.90M | $3.22M | $1.36M |
| Stock-Based Compensation | $827K | $1.56M | $2.15M | $2.62M | $12.60M | $1.98M | $624K | $600K | $7.08M | $1.46M |
| Change in Receivables | -- | -- | -- | -- | -- | -- | $1.49M | $967K | -$779K | -$3.19M |
| **Operating Cash Flow** | -$8.14M | -$7.73M | -$14.09M | -$17.15M | -$11.46M | -$3.89M | -$648K | -$2.57M | -$2.74M | -$2.70M |
| Capital Expenditure | -- | -- | -$5.2K | -$584K | -$190K | -- | -- | -- | -- | -- |
| **Free Cash Flow** | -- | -- | -$14.10M | -$17.73M | -$11.65M | -- | -- | -- | -- | -- |
| Acquisitions, Net | -- | -- | -- | -- | -- | -- | -$200K | -$3.65M | -$165K | -$6.56M |
| **Investing Cash Flow** | -- | -- | $12K | -$584K | $2.19M | -$44K | -$284K | -$3.64M | -$170K | -$6.59M |
| Common Stock Issued | -- | $2.29M | -- | $17.22M | $21.61M | $488K | $2.12M | $6.33M | $4.90M | $5.00M |
| **Financing Cash Flow** | $10.58M | $7.67M | -$1.34M | $18.18M | $24.90M | $5.53M | $560K | $2.69M | $6.41M | $8.80M |
| **Net Change in Cash** | $2.44M | -$47K | -$15.44M | $368K | $15.78M | $1.53M | -$70K | -$3.51M | $3.50M | -$498K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.55M | -$3.03M | -$1.63M | -$2.19M | -$1.87M | -$2.52M | -$2.18M | -$3.15M |
| Depreciation & Amortization | $35K | $37K | $37K | $39K | $40K | $40K | $81K | $82K |
| Stock-Based Compensation | $199K | $125K | $89K | $240K | $187K | $206K | $194K | $472K |
| **Operating Cash Flow** | -$2.65M | -$2.44M | -$2.26M | -$1.78M | -$2.07M | -$1.89M | -$2.39M | -$1.31M |
| Common Stock Issued | $0 | -$7.4K | $1.30M | -- | -- | -- | -- | $0 |
| **Financing Cash Flow** | -$29K | $5.84M | $2.50M | $2.69M | $2.99M | $449K | $4.45M | $463K |
| **Net Change in Cash** | -$2.68M | $3.39M | $231K | $920K | $908K | -$1.44M | $2.05M | -$871K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | -- | -- | -- | -- | -- | -- | 20.4% | 20.9% | 21.1% | 19.2% |
| **Operating Margin** | -- | -- | -- | -- | -- | -- | -5.8% | -16.6% | -22.4% | -14.9% |
| **Net Profit Margin** | -- | -- | -- | -- | -- | -- | -6.0% | -39.3% | -18.7% | -7.7% |
| Return on Equity (ROE) | -210.0% | -601.1% | -883.9% | -125.9% | -219.6% | -201.0% | -- | -- | -46.7% | -23.8% |
| Return on Assets (ROA) | -172.1% | -310.6% | -402.1% | -94.5% | -183.3% | -167.6% | -2215.9% | -57.0% | -17.4% | -7.0% |
| Current Ratio | 5.38x | 1.84x | 1.53x | 4.61x | 6.48x | 3.35x | 0.01x | 0.68x | 0.48x | 0.79x |
| Quick Ratio | 5.09x | 1.50x | 0.98x | 4.44x | 6.34x | 2.32x | 0.50x | 0.63x | 0.45x | 0.75x |
| Debt to Equity | -- | -- | -- | 0.00x | 0.01x | -- | -- | -- | 0.34x | 0.47x |
| **Revenue Growth (YoY)** | -- | -- | -- | -- | -- | -- | -7.2% | -11.5% | +34.4% | -- |
| Gross Profit Growth (YoY) | -- | -- | -- | -- | -- | -- | -9.3% | -12.3% | +47.8% | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -164.2% | -108.0% | -162.4% | -210.0% | -281.6% | -455.1% | -237.5% | -601.1% |
| Return on Assets (ROA) | -147.6% | -97.6% | -148.9% | -172.1% | -223.1% | -280.2% | -182.3% | -310.6% |
| Current Ratio | 9.70x | 10.21x | 11.67x | 5.38x | 4.60x | 2.43x | 4.08x | 1.84x |
| Quick Ratio | 8.71x | 9.63x | 10.66x | 5.09x | 4.15x | 2.09x | 3.63x | 1.50x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
